UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 11, 2017
BRUKER CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
|
000-30833 |
|
04-3110160 |
40 Manning Road
Billerica, MA 01821
(Address of principal executive offices)(Zip Code)
Registrants telephone number, including area code: (978) 663-3660
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the reporting obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 of the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
|
Emerging growth company o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Section 8 Other Events
Item 8.01. Other Events.
On May 11, 2017, the Board of Directors of Bruker Corporation (the Company) approved a share repurchase program authorizing the purchase of up to $225 million of the Companys common stock over a two-year period commencing May 12, 2017 and declared a quarterly cash dividend in the amount of $0.04 per share on the Companys common stock. The dividend will be paid on June 23, 2017 to stockholders of record as of June 5, 2017.
Under the share repurchase program, the Company may repurchase its common stock from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Companys repurchases may be executed using open market purchases, privately negotiated purchases or other transactions during the period from May 12, 2017 to May 11, 2019. The Company intends to fund repurchases under the share repurchase program from cash on hand and available borrowings under its existing credit facility. The share repurchase program does not obligate the Company to repurchase any specific number of shares and may be suspended, modified or terminated at any time without prior notice.
A copy of the Companys press release announcing approval of the $225 million share repurchase program and the quarterly dividend payment is attached as Exhibit 99.1 to this Current Report on Form 8-K.
FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements, including, but not limited to, statements regarding the Companys commitment to repurchasing its shares at any level in the future, the anticipated value of shares to be repurchased by the Company, the expected timing of such repurchases and the availability of funds for the repurchase of shares. These forward-looking statements are based on current information and expectations, and involve a number of risks and uncertainties. Actual future results and/or events may differ materially from such expectations as a result of important risk factors, which include, in addition to those identified in the Companys Form 10-K for the year ended December 31, 2016 and its other filings with the Securities and Exchange Commission: a change in the Companys share repurchase program by the Companys Board of Directors or management, including changes in the value of shares to be repurchased or the timing of such repurchases, and unanticipated material payment obligations incurred by the Company that decrease the Companys willingness or ability to repurchase shares at the anticipated level and timing, or at all. These risks and uncertainties could cause actual results to differ materially from those referred to in these forward-looking statements. The Company expressly disclaims any obligation to update or revise these forward-looking statements, except as otherwise specifically stated by the Company or as required by law or regulation.
Section 9 Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) |
Exhibits |
|
|
|
Number |
|
|
|
99.1 Press release dated May 12, 2017. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BRUKER CORPORATION | |
|
(Registrant) | |
|
|
|
Date: May 12, 2017 |
By: |
/s/ANTHONY L. MATTACCHIONE |
|
|
Anthony L. Mattacchione |
|
|
Senior Vice President and |
|
|
Interim Chief Financial Officer |
Exhibit 99.1
Bruker Announces New $225 Million Share Repurchase Program and Quarterly Dividend
BILLERICA, Mass. May 12, 2017 Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved a new share repurchase program authorizing the purchase of up to $225 million of the Companys common stock over a two-year period commencing May 12, 2017.
Under this program, the Company may repurchase its common stock from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Companys repurchases may be executed using open market purchases, privately negotiated purchases or other transactions during the period from May 12, 2017 to May 11, 2019.
The Company intends to fund repurchases under this share repurchase program from cash on hand and available borrowings under its existing credit facility. The share repurchase program does not obligate the Company to repurchase any specific number of shares, and may be suspended, modified or terminated at any time without prior notice.
With our strong balance sheet, ongoing margin expansion and cash flow generation progress, we are continuing our share repurchases with the approval of a new $225 million, two-year program, said Tony Mattacchione, Brukers Senior Vice President and Chief Financial Officer. We are confident in our ability to fund our organic growth initiatives and further portfolio transformation, while staying committed to disciplined capital deployment and to adding value to both Bruker and its shareholders.
Bruker Corporation also announced today that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Companys common stock. The dividend will be paid on June 23, 2017 to stockholders of record as of June 5, 2017.
About Bruker Corporation
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Brukers high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications. In recent years, Bruker has also become a provider of high-performance systems for cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology, and for molecular pathology research. For more information, please visit: www.bruker.com.
Forward Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements regarding the Companys commitment to repurchasing its shares at any level in the future, the anticipated value of shares to be repurchased by the Company, the expected timing of such repurchases and the availability of funds for the repurchase of shares. These forward-looking statements are based on current information and expectations, and involve a number of risks and uncertainties. Actual future results and/or events may differ materially from such expectations as a result of important risk factors, which include, in addition to those identified in the
Companys Form 10-K for the year ended December 31, 2016 and its other filings with the Securities and Exchange Commission: a change in the Companys share repurchase program by the Companys Board of Directors or management, including changes in the value of shares to be repurchased or the timing of such repurchases, and unanticipated material payment obligations incurred by the Company that decrease the Companys willingness or ability to repurchase shares at the anticipated level and timing, or at all. These risks and uncertainties could cause actual results to differ materially from those referred to in these forward-looking statements. The Company expressly disclaims any obligation to update or revise these forward-looking statements, except as otherwise specifically stated by the Company or as required by law or regulation.
# # #
Contacts:
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 3660, ext. 1479
E: Miroslava.Minkova@Bruker.com
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